Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: ACS Chem Neurosci. 2021 Dec 2;12(24):4524–4534. doi: 10.1021/acschemneuro.1c00557

Table 3.

Structure and Activities of Analogs 22a

graphic file with name nihms-1774857-t0019.jpg
Compound R PAR4-AP PAC-1 IC50 (μM)b (pIC50±SEM) PAR4-AP % Max PAC-1a PARI %Maxc
7 0.18 (6.74±0.06) 0.32 98
22a graphic file with name nihms-1774857-t0020.jpg 0.32 (6.49±0.03) 0.66 84
22b graphic file with name nihms-1774857-t0021.jpg 2.4 (5.61±0.13) 5.1 80
22c graphic file with name nihms-1774857-t0022.jpg 0.16 (6.79±0.04) −1.2 92
22d graphic file with name nihms-1774857-t0023.jpg 0.63 (6.2±0.09) 1.3 81
22e graphic file with name nihms-1774857-t0024.jpg 2.1 (5.67±0.10) 11 90
(5.67±0.10)
22f graphic file with name nihms-1774857-t0025.jpg 0.24 (6.61±0.05) 0.32 92
22g graphic file with name nihms-1774857-t0026.jpg 1.3 (5.88±0.13) 4.2 85
22h graphic file with name nihms-1774857-t0027.jpg 1.2 (5.92±0.11) 2.84 76
a

Values indicate the percentage of max PAC-1 binding after PAR4-AP stimulation of human platelets.

b

Average of three independent determinations.

c

Values indicate the percentage PAR1 activity in the presence of 10 μM compound.